Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 42,723 | 42,657 | 70,144 | 30,806 | 27,396 |
| Cost of Goods | 30,691 | 28,914 | 36,607 | 23,107 | 19,018 |
| Gross Profit | 12,032 | 13,743 | 33,537 | 7,699 | 8,378 |
| Operating Expenses | 8,117 | 7,539 | 6,512 | 5,420 | 4,839 |
| Operating Income | 4,606 | 7,118 | 27,632 | 2,386 | 3,557 |
| Interest Expense | 524 | 436 | 1,171 | 379 | 326 |
| Other Income | -217 | 125 | 1,658 | -463 | 453 |
| Pre-tax Income | 3,865 | 6,807 | 28,119 | 1,544 | 3,684 |
| Income Tax | 1,563 | 2,873 | 11,222 | 871 | 1,533 |
| Net Income Continuous | 2,302 | 3,934 | 16,897 | 673 | 2,151 |
| Net Income | $2,302 | $3,934 | $16,897 | $673 | $2,151 |
| EPS Basic Total Ops | 0.42 | 0.72 | 3.17 | 0.13 | 0.41 |
| EPS Basic Continuous Ops | 0.42 | 0.72 | 3.17 | 0.12 | 0.41 |
| EPS Diluted Total Ops | 0.40 | 0.68 | 2.97 | 0.12 | 0.41 |
| EPS Diluted Continuous Ops | 0.39 | 0.66 | 2.94 | 0.12 | 0.41 |
| EBITDA(a) | $5,408 | $8,126 | $29,112 | $3,434 | $3,916 |